Please use this identifier to cite or link to this item:
Title: Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog
Authors: Ngow, Yeen Shian
Rajan, Sreekanth
Ye, Hong
Yoon, Ho Sup
Keywords: Kinase
Mitotic Kinase
Science::Biological sciences
Issue Date: 2018
Source: Ngow, Y. S., Rajan, S., Ye, H., & Yoon, H. S. (2019). Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog. Protein Science, 28(3), 524-532. doi:10.1002/pro.3552
Series/Report no.: Protein Science
Abstract: Vaccinia‐related kinase 1 (VRK1), a serine/threonine mitotic kinase, is widely over‐expressed in dividing cells and regarded as a cancer drug target primarily due to its function as an early response gene in cell proliferation. However, the mechanism of VRK1 phosphorylation and substrate activation is not well understood. More importantly even the molecular basis of VRK1 interaction with its cofactor, adenosine triphosphate (ATP), is unavailable to‐date. As designing specific inhibitors remains to be the major challenge in kinase research, such a molecular understanding will enable us to design ATP‐competitive specific inhibitors of VRK1. Here we report the molecular characterization of VRK1 in complex with AMP‐PNP, a non‐hydrolyzable ATP‐analog, using NMR titration followed by the co‐crystal structure determined upto 2.07 Å resolution. We also carried out the structural comparison of the AMP‐PNP bound‐form with its apo and inhibitor‐bound counterparts, which has enabled us to present our rationale toward designing VRK1‐specific inhibitors.
ISSN: 0961-8368
DOI: 10.1002/pro.3552
Rights: © 2018 The Protein Society. All rights reserved.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:SBS Journal Articles

Citations 50

Updated on Jan 13, 2023

Web of ScienceTM
Citations 50

Updated on Jan 23, 2023

Page view(s)

Updated on Jan 29, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.